These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 10737693)
21. Impact of APOE in mild cognitive impairment. Farlow MR; He Y; Tekin S; Xu J; Lane R; Charles HC Neurology; 2004 Nov; 63(10):1898-901. PubMed ID: 15557508 [TBL] [Abstract][Full Text] [Related]
23. APOE ε4 allele is associated with worse performance in memory dimensions of the mini-mental state examination: the Bambuí Cohort Study of Aging. Quintino-Santos S; Diniz BS; Firmo JO; Moriguchi EH; Lima-Costa MF; Castro-Costa E Int J Geriatr Psychiatry; 2015 Jun; 30(6):573-9. PubMed ID: 25132317 [TBL] [Abstract][Full Text] [Related]
24. Effects of ApoE-epsilon4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons. Crivello F; Lemaître H; Dufouil C; Grassiot B; Delcroix N; Tzourio-Mazoyer N; Tzourio C; Mazoyer B Neuroimage; 2010 Nov; 53(3):1064-9. PubMed ID: 20060049 [TBL] [Abstract][Full Text] [Related]
25. APOE polymorphisms and cognitive functions in patients with brain tumors. Correa DD; Satagopan J; Baser RE; Cheung K; Richards E; Lin M; Karimi S; Lyo J; DeAngelis LM; Orlow I Neurology; 2014 Jul; 83(4):320-7. PubMed ID: 24944262 [TBL] [Abstract][Full Text] [Related]
26. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169 [TBL] [Abstract][Full Text] [Related]
27. Lower cognitive performance of older football players possessing apolipoprotein E epsilon4. Kutner KC; Erlanger DM; Tsai J; Jordan B; Relkin NR Neurosurgery; 2000 Sep; 47(3):651-7; discussion 657-8. PubMed ID: 10981753 [TBL] [Abstract][Full Text] [Related]
28. Patterns of brain activation in people at risk for Alzheimer's disease. Bookheimer SY; Strojwas MH; Cohen MS; Saunders AM; Pericak-Vance MA; Mazziotta JC; Small GW N Engl J Med; 2000 Aug; 343(7):450-6. PubMed ID: 10944562 [TBL] [Abstract][Full Text] [Related]
29. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. Haan MN; Shemanski L; Jagust WJ; Manolio TA; Kuller L JAMA; 1999 Jul; 282(1):40-6. PubMed ID: 10404910 [TBL] [Abstract][Full Text] [Related]
30. Impact of APOE status on cognitive maintenance in healthy elderly persons. Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849 [TBL] [Abstract][Full Text] [Related]
31. Associations between APOE genotype and cerebral small-vessel disease: a longitudinal study. Luo X; Jiaerken Y; Yu X; Huang P; Qiu T; Jia Y; Li K; Xu X; Shen Z; Guan X; Zhou J; Zhang M; Adni FTADNI Oncotarget; 2017 Jul; 8(27):44477-44489. PubMed ID: 28574812 [TBL] [Abstract][Full Text] [Related]
32. Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers. Sun Y; Wang X; Wang Y; Dong H; Lu J; Scheininger T; Ewers M; Jessen F; Zuo XN; Han Y Alzheimers Res Ther; 2019 Jun; 11(1):50. PubMed ID: 31159873 [TBL] [Abstract][Full Text] [Related]
33. Differential effects of the APOE genotype on brain function across the lifespan. Filippini N; Ebmeier KP; MacIntosh BJ; Trachtenberg AJ; Frisoni GB; Wilcock GK; Beckmann CF; Smith SM; Matthews PM; Mackay CE Neuroimage; 2011 Jan; 54(1):602-10. PubMed ID: 20705142 [TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease. Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419 [TBL] [Abstract][Full Text] [Related]
35. APOE ε4 differentially influences change in memory performance depending on age. The SMART-MR study. Jochemsen HM; Muller M; van der Graaf Y; Geerlings MI Neurobiol Aging; 2012 Apr; 33(4):832.e15-22. PubMed ID: 21908077 [TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults. Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298 [TBL] [Abstract][Full Text] [Related]
37. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Knopman DS; Mosley TH; Catellier DJ; Coker LH; Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884 [TBL] [Abstract][Full Text] [Related]
38. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e. Susanto TA; Pua EP; Zhou J; J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955 [TBL] [Abstract][Full Text] [Related]
39. The Value of Brain Structural Magnetic Resonance Imaging Combined with APOE-- Zhao W; Yin C; Yu F; Wan L; Che S; Cui L Contrast Media Mol Imaging; 2022; 2022():8613024. PubMed ID: 35317127 [TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia. Lavretsky H; Ercoli L; Siddarth P; Bookheimer S; Miller K; Small G Am J Geriatr Psychiatry; 2003; 11(6):667-73. PubMed ID: 14609807 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]